Which of the following statements about kidney transplantation rejection should the nurse include in patient education?

Choice A rationale The fundamental principle of preventing graft rejection involves the pharmacological suppression of the recipient immune system. Immunosuppressive medications, such as corticosteroids, calcineurin inhibitors like tacrolimus, and antimetabolites like mycophenolate mofetil, work by inhibiting T-cell activation and proliferation. By reducing the immune response against the non-self HLA antigens of the donor kidney, these drugs prevent the body from attacking the new organ. This lifelong therapy is essential for maintaining long-term graft survival. Choice B rationale Chronic rejection is a slow, progressive immunological and non-immunological process resulting in irreversible fibrosis and scarring of the renal parenchyma. Unlike acute rejection, which often responds to increased doses of immunosuppressants or pulse steroids, chronic rejection is generally refractory to augmented immunosuppression. Management focuses on controlling blood pressure, managing lipids, and optimizing current medication levels to slow the decline of renal function rather than reversing the underlying chronic damage already sustained by the organ. Choice C rationale Comprehensive postoperative education is a critical component of transplant success and patient safety. Patients must understand the physiological signs of rejection, such as fever, decreased urine output, and graft tenderness, to seek medical intervention immediately. Lack of education increases the risk of medication non-adherence and delayed recognition of complications. Understanding the rejection process empowers patients to participate in their care, which significantly correlates with improved long-term clinical outcomes and graft longevity. Choice D rationale Clinical presentations vary significantly based on the timing and mechanism of rejection. Hyperacute rejection occurs within minutes due to preformed antibodies, leading to immediate thrombosis. Acute rejection, occurring days to months later, may present with systemic symptoms like fever and elevated creatinine levels. Chronic rejection is often asymptomatic initially, manifesting only as a gradual decline in the glomerular filtration rate over years. Therefore, nurses must teach that symptoms are not uniform across all types of rejection. Choice E rationale Hyperacute rejection is a type II hypersensitivity reaction caused by pre-existing antibodies against the donor's ABO blood group or HLA antigens. This results in immediate complement activation, massive intravascular coagulation, and hemorrhagic necrosis of the graft. Because this process is irreversible and occurs almost instantly upon anastomosis of the vessels, the only clinical intervention is the immediate surgical removal of the transplanted kidney to prevent systemic inflammatory response syndrome and further life-threatening complications. Choice F rationale Dialysis is not a universal requirement for monitoring or managing all rejection episodes. While dialysis may be necessary if a rejection episode leads to severe acute kidney injury or complete graft failure, many acute rejection episodes are successfully managed with high-dose intravenous medications without the need for renal replacement therapy. Monitoring graft function primarily involves serial measurements of serum creatinine, blood urea nitrogen, and urine output, alongside renal biopsies, rather than the routine use of dialysis.